United States Pharmaceutical Contract Packaging Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “United States pharmaceutical contract packaging market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the United States pharmaceutical contract packaging market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The United States pharmaceutical contract packaging market size reached US$ 5.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.75% during 2023-2028.
Pharmaceutical contract packaging is a practice that entails entrusting external providers with the essential tasks of packaging and labeling pharmaceutical products. This practice holds significant importance in the seamless packaging and labeling of pharmaceutical items, ensuring strict adherence to regulatory requirements, and optimizing the entire supply chain process. By leveraging this approach, pharmaceutical manufacturers can concentrate on their primary strengths while relying on specialized partners to handle the intricacies of packaging and labeling. As it aids in streamlining operations, upholding product integrity, and meeting rigorous quality benchmarks, the demand for pharmaceutical contract packaging is on the rise in the United States.
United States Pharmaceutical Contract Packaging Market Trends and Drivers:
Currently, a heightened emphasis on cost-effectiveness and resource optimization stands as a primary driver of market growth in the United States. Additionally, the surging demand for precise, tailored packaging solutions is contributing positively to the market's prospects in the country. Moreover, the rising popularity of advanced technologies such as smart packaging and serialization, aimed at enhancing product security and improving the patient experience, is further propelling market growth in the United States. Furthermore, the escalating need for improved traceability, anti-counterfeiting measures, and enhanced patient engagement is presenting lucrative growth opportunities for industry investors within the nation. Additionally, the increasing adoption of pharmaceutical contract packaging to sidestep substantial investments in in-house packaging infrastructure is providing significant support to market expansion in the United States.
The report segmented the market on the basis of region, industry, type and packaging.
Breakup by Industry:
- Small Molecule
- Biopharmaceutical
- Vaccine
Breakup by Type:
- Sterile
- Non-Sterile
Breakup by Packaging:
- Plastic Bottles
- Caps and Closures
- Blister Packs
- Prefilled Syringes
- Parenteral Vials and Ampoules
- Others
Breakup by Region:
- Northeast
- Midwest
- South
- West
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
